Meiji Yasuda Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.97M | Sell |
123,310
-322
| -0.3% | -$8.42K | 0.13% | 190 |
|
|
2026
Q1 | $3.47M | Sell |
123,632
-1,901
| -2% | -$50.6K | 0.17% | 158 |
|
|
2025
Q4 | $3.13M | Buy |
125,533
+55
| +0% | +$1.39K | 0.15% | 171 |
|
|
2025
Q3 | $3.2M | Sell |
125,478
-388
| -0.3% | -$9.58K | 0.15% | 169 |
|
|
2025
Q2 | $3.05M | Sell |
125,866
-67,973
| -35% | -$1.59M | 0.15% | 166 |
|
|
2025
Q1 | $4.91M | Sell |
193,839
-216
| -0.1% | -$5.65K | 0.2% | 133 |
|
|
2024
Q4 | $5.15M | Buy |
194,055
+2,974
| +2% | +$80.7K | 0.2% | 137 |
|
|
2024
Q3 | $5.53M | Buy |
191,081
+270
| +0.1% | +$7.88K | 0.21% | 121 |
|
|
2024
Q2 | $5.34M | Buy |
190,811
+2,572
| +1% | +$70.8K | 0.22% | 121 |
|
|
2024
Q1 | $5.22M | Sell |
188,239
-78,335
| -29% | -$2.17M | 0.22% | 125 |
|
|
2023
Q4 | $7.67M | Sell |
266,574
-98,334
| -27% | -$2.97M | 0.35% | 86 |
|
|
2023
Q3 | $12.1M | Buy |
364,908
+51,311
| +16% | +$1.81M | 0.57% | 39 |
|
|
2023
Q2 | $11.5M | Sell |
313,597
-8,620
| -3% | -$336K | 0.57% | 41 |
|
|
2023
Q1 | $13.1M | Sell |
322,217
-17,907
| -5% | -$773K | 0.68% | 29 |
|
|
2022
Q4 | $17.4M | Buy |
340,124
+5,213
| +2% | +$250K | 0.84% | 20 |
|
|
2022
Q3 | $14.7M | Sell |
334,911
-11,739
| -3% | -$570K | 0.85% | 19 |
|
|
2022
Q2 | $18.2M | Buy |
346,650
+5,495
| +2% | +$280K | 1.06% | 13 |
|
|
2022
Q1 | $17.7M | Sell |
341,155
-24,708
| -7% | -$1.28M | 0.97% | 14 |
|
|
2021
Q4 | $21.6M | Sell |
365,863
-1,188
| -0.3% | -$58.9K | 1.34% | 10 |
|
|
2021
Q3 | $15.8M | Sell |
367,051
-3,928
| -1% | -$174K | 1.12% | 15 |
|
|
2021
Q2 | $14.5M | Sell |
370,979
-8,495
| -2% | -$330K | 0.69% | 36 |
|
|
2021
Q1 | $13.7M | Buy |
379,474
+107,168
| +39% | +$3.81M | 1.02% | 18 |
|
|
2020
Q4 | $10M | Sell |
272,306
-5,951
| -2% | -$218K | 0.99% | 18 |
|
|
2020
Q3 | $9.69M | Sell |
278,257
-44,943
| -14% | -$1.58M | 1.06% | 18 |
|
|
2020
Q2 | $10M | Buy |
323,200
+91,655
| +40% | +$3.11M | 0.95% | 19 |
|
|
2020
Q1 | $7.17M | Sell |
231,545
-116,842
| -34% | -$3.98M | 1.35% | 12 |
|
|
2019
Q4 | $12.9M | Sell |
348,387
-42,265
| -11% | -$1.51M | 1.09% | 14 |
|
|
2019
Q3 | $13.3M | Buy |
390,652
+11,334
| +3% | +$412K | 1.08% | 14 |
|
|
2019
Q2 | $15.6M | Sell |
379,318
-45,330
| -11% | -$1.8M | 1.31% | 8 |
|
|
2019
Q1 | $17.1M | Sell |
424,648
-11,856
| -3% | -$475K | 1.45% | 6 |
|
|
2018
Q4 | $18.1M | Sell |
436,504
-15,308
| -3% | -$635K | 1.69% | 6 |
|
|
2018
Q3 | $18.9M | Buy |
451,812
+11,584
| +3% | +$446K | 1.54% | 6 |
|
|
2018
Q2 | $15.2M | Buy |
440,228
+25,243
| +6% | +$863K | 1.35% | 9 |
|
|
2018
Q1 | $14M | Buy |
414,985
+13,294
| +3% | +$457K | 1.33% | 8 |
|
|
2017
Q4 | $13.8M | Sell |
401,691
-6,250
| -2% | -$213K | 1.31% | 8 |
|
|
2017
Q3 | $13.8M | Buy |
407,941
+2,424
| +0.6% | +$77.9K | 1.36% | 8 |
|
|
2017
Q2 | $12.9M | Buy |
405,517
+24,990
| +7% | +$788K | 1.32% | 8 |
|
|
2017
Q1 | $12.4M | Sell |
380,527
-4,812
| -1% | -$152K | 1.32% | 6 |
|
|
2016
Q4 | $11.9M | Buy |
385,339
+4,625
| +1% | +$141K | 1.33% | 7 |
|
|
2016
Q3 | $12.2M | Buy |
380,714
+49,464
| +15% | +$1.65M | 1.43% | 6 |
|
|
2016
Q2 | $11.1M | Buy |
331,250
+88,331
| +36% | +$2.82M | 1.59% | 5 |
|
|
2016
Q1 | $6.83M | Sell |
242,919
-5,512
| -2% | -$157K | 1.55% | 8 |
|
|
2015
Q4 | $7.61M | Buy |
248,431
+11,454
| +5% | +$360K | 1.72% | 6 |
|
|
2015
Q3 | $7.06M | Buy |
236,977
+13,177
| +6% | +$422K | 1.73% | 6 |
|
|
2015
Q2 | $7.12M | Sell |
223,800
-350
| -0.2% | -$11.4K | 1.67% | 7 |
|
|
2015
Q1 | $7.4M | Sell |
224,150
-769
| -0.3% | -$24.4K | 1.79% | 5 |
|
|
2014
Q4 | $6.65M | Sell |
224,919
-11,357
| -5% | -$326K | 1.6% | 6 |
|
|
2014
Q3 | $6.63M | Sell |
236,276
-44,584
| -16% | -$1.25M | 1.56% | 7 |
|
|
2014
Q2 | $7.91M | Sell |
280,860
-6,723
| -2% | -$192K | 1.63% | 7 |
|
|
2014
Q1 | $8.76M | Sell |
287,583
-12,334
| -4% | -$368K | 1.89% | 6 |
|
|
2013
Q4 | $8.72M | Sell |
299,917
-6,775
| -2% | -$197K | 1.84% | 6 |
|
|
2013
Q3 | $8.35M | Sell |
306,692
-14,471
| -5% | -$394K | 1.89% | 4 |
|
|
2013
Q2 | $8.56M | Buy |
+321,163
| New | +$8.87M | 2.02% | 5 |
|
Other funds holding PFE
Meiji Yasuda Asset Management's PFE Position: Q2 2026 in Review
Meiji Yasuda Asset Management reduced its Pfizer (PFE) stake by 0.26% in Q2 2026, selling an estimated $8.42K and leaving 123,310 shares worth $2.97M. The position accounts for 0.13% of the portfolio, ranked #190.
Meiji Yasuda Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.6M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Meiji Yasuda Asset Management held 123,310 shares of Pfizer worth $2.97M as of Q2 2026.
- Meiji Yasuda Asset Management sold 322 Pfizer shares in Q2 2026, an estimated $8.42K.
- Pfizer made up 0.13% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #190 holding.
- Meiji Yasuda Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Meiji Yasuda Asset Management's Pfizer position peaked at $21.6M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.